1. Home
  2. BV vs GHRS Comparison

BV vs GHRS Comparison

Compare BV & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BV

BrightView Holdings Inc.

HOLD

Current Price

$12.75

Market Cap

1.2B

ML Signal

HOLD

Logo GH Research PLC

GHRS

GH Research PLC

HOLD

Current Price

$22.97

Market Cap

947.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BV
GHRS
Founded
1939
2018
Country
United States
Ireland
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
947.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BV
GHRS
Price
$12.75
$22.97
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$14.50
$41.38
AVG Volume (30 Days)
631.6K
190.3K
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.61
N/A
Revenue Next Year
$1.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.06
$10.96
52 Week High
$17.11
$24.66

Technical Indicators

Market Signals
Indicator
BV
GHRS
Relative Strength Index (RSI) 55.53 63.53
Support Level $12.56 $12.65
Resistance Level $12.93 $24.66
Average True Range (ATR) 0.36 1.48
MACD 0.01 -0.08
Stochastic Oscillator 78.77 81.68

Price Performance

Historical Comparison
BV
GHRS

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: